Ebitda Alterar Data
Cara Therapeutics USD -2.39M 3.16M 2025-03
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -8.84M 180K 2026-06
Cronos Group USD 17.08M 6.1M 2026-09
RedHill Biopharma USD 2.69M 108.46M 2023-06